
Last updated: 2026-10-13 16:02:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Teleflex Incorporated (TFX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $125.01, with a market capitalisation of $5.30B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $100.18 to $145.00. This page covers its latest market performance, valuation, price trends and company information.
$5.30B | |
$125.64 | |
$449.38 | |
$37.21 | |
$125.70 | |
171.35K | |
669.74K | |
-- | |
$145.00 | |
$100.18 | |
1.12% | |
-- |
Teleflex Incorporated (TFX) is currently trading at $125.01 as of 2026-10-13 15:46:49, down 0.55% ($0.69) from the previous close of $125.70
During today's regular trading session, TFX has traded between $37.21 and $449.38, with a trading volume of 171.35K shares. The current price is near the lower end of today's range.
Over the past seven days, Teleflex Incorporated (TFX) moved from $124.12 to $125.01, representing a gain of 0.72% ($0.89).
The stock traded between $122.06 and $127.44 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 695.41 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 55.4%
TFX is currently trading at $125.01, placing it 55.4% of the way from its 52-week low of $100.18 to its 52-week high of $145.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 15500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Teleflex Incorporated (TFX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.